1. Up to 12 Months of Elagolix Sustained Menstrual Blood Loss Reduction in Women With Uterine Fibroids [OP04-5D]. (May 2020) Authors: Simon, James A.; Bradley, Linda D.; Liu, Ran; Owens, Charlotte; Schlaff, William Journal: Obstetrics and gynecology Issue: Volume 135(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗